1 HIV, Tuberculosis and Criminal Justice The Perfect Storm Frederick L. Altice, M.D., M.A. Professor of Medicine and Public Health Yale University (USA)

Slides:



Advertisements
Similar presentations
Tuberculosis (TB): clinical diagnosis and management of tuberculosis and measures for its prevention and control March 2006.
Advertisements

Combined prevention programs within criminal justice systems – examples from Malaysia A Kamarulzaman, S Kaur, MN Nazar, M Azahari, C Koh, H AlDarraji,
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
GAP Report 2014 Prisoners People left behind: Prisoners Link with the pdf, Prisoners.
Treatment Of Medical, Psychiatric, and Substance Use Co-morbidities In People Infected With HIV Who Use Drugs Frederick L. Altice (US, Malaysia, Ukraine)
Mary Foote MD, MPH 1 Infectious Disease Fellow Anne Spaulding MD, MPH 1,2 1 Emory University Schools of Medicine and 2 Public Health Atlanta, Georgia Georgia.
U. S. Senate Briefing World TB Day Celine Gounder, MD, ScM Center for TB Research, Johns Hopkins University Director for Delivery, CREATE On behalf of.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Annabel Baddeley Global TB Programme WHO, Geneva
Integrating TB into PWID Services in Indonesia The Works in Progress Dr Siti Nadia, NAP Manager; Dr Dyah Erti Mustikawati, NTP Manager Melbourne AIDS Conference.
West Virginia’s Tuberculosis Control Program Hx and Epi MissionTransmissionRequirements Channels of Communication.
Latent Tuberculosis among Displaced Populations Rapid Diagnosis and Control Nikolaou Aristidis MD, MSc.
Kuala Lumpur, Malaysia, 30 June - 3 July 2013 Implications for Countries: Critical Issues in Service Delivery and Decision Making Dr. Yogan Pillay Deputy.
Unit 5: IPT Isoniazid TB Preventive Therapy
Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South Africa.
HIV AIDS Section Fabienne Hariga Senior Adviser UNODC HIV AIDS section, Vienna Comprehensive package of interventions for HIV in prison settings AIDS 2012.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
Treatment of drug addiction in prisons
Module 3: HCV prevalence and course of HCV infection.
The Effect of Opioid Agonist Maintenance Therapy on Healthcare Utilization and Engagement among HIV-infected People Who Inject Drugs in.
Modelling the role of household versus community transmission of TB in Zimbabwe Georgie Hughes Supervisor: Dr Christine Currie (University of Southampton)
Use of Network Analysis During a Tuberculosis Investigation Outbreak Investigation Section Surveillance and Epidemiology Branch Division of Tuberculosis.
Improving TB-DM Care in the Pacific: Partnerships and Progress R. Brostrom, MD-MSPH Hawaii TB Control Branch Chief Regional TB Field Medical Officer, CDC-DTBE.
M ALNUTRITION. M ALNUTRITION AMONG IDU S : B ASIC FACTS Drug users are at increased risk of malnutrition regardless of whether or not they are infected.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,
Epidemiology of tuberculosis. Peymane Adab, Richard Fielding, Susana Castan.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Treatment Last updated: December 2014.
Tuberculosis What is tuberculosis?.
Progress of the Singapore TB Elimination Programme (STEP)
Sanghyuk Shin, PhD Department of Epidemiology UCLA Fielding School of Public Health Aug 27, 2015 Tuberculosis and HIV Co-infection: “A Deadly Syndemic”
Incarceration, Reentry and Disparities in Health: What are the connections? Nicholas Freudenberg Hunter College, May 5, 2006 Presented at the Prisoner.
TUBERCULOSIS TRANSMISSION IN A SOUTH AFRICAN PRISON Robin Wood Desmond Tutu HIV Centre Institute of Infectious Disease & Molecular Medicine University.
Module 2 - Epidemiology of Tuberculosis
Screening for TB.
Return on investment: How do whole societies benefit from improved services and coverage for key populations? Bradley Mathers Kirby Institute UNSW Australia.
HIV/TB – Case Studies David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Pennsylvania: The State of HCV 2015
Kow-Tong Chen, M.D., Ph.D., Hsiao-Ling Chang, Ph.D., Chu-Tzu Chen, M.P.H., and Ying-An Chen, M.P.H. Volume 23, Number 3, 2009 AIDS PATIENT CARE and STDs.
Colleen Daniels Stop TB Department World Health Organisation TB, HIV and Drug Use The overview.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 8.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
Diagnostics - More than 100 years old Drugs – Last drug 40 years old Vaccine – Nearly 90 years old Lucica Ditiu Executive Secretary, Stop TB Partnership.
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS Overcoming the Challenges of Providing HIV Prevention and Treatment Services for People Who Inject.
HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.
GLOBAL TB PROGRAMME Systematic screening for active TB – operational manual and tool to help prioritization Wolfheze 2015 Knut Lönnroth, Global TB Programme.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Tuberculosis in Children and Young Adults
Lessons Learned and Novel Investigation Techniques in Response to a Large Community Outbreak of HIV-1 infection Philip J. Peters MD HIV Testing and Biomedical.
Rauni Ruohonen FILHA Priorities of TB control in penitentiary care.
PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
Cascade of care for people who use drugs - opportunities for integration and scale up of harm reduction services and other evidence based interventions.
Integrating HIV, TB and Addiction Treatment in Malaysian Prisons
Incarceration and People Who Inject Drugs in Ukraine: Modelling its Role in HIV Transmission and the Impact of Introducing OST in Prisons Jack Stone, Ellen.
Government of Swaziland
Prisons and TB in Europe
Please add short title; delete red text
Global burden of HIV, viral hepatitis and TB in prisoners
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Mark Lobato, MD Division of TB Elimination
HIV and related infections in prisoners
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
Tuberculosis in prisons TUBS02
The HIV Epidemic among People who Inject Drugs
Collaborative TB/HIV activities in European Region
Strategic framework for TB/HIV
Presentation transcript:

1 HIV, Tuberculosis and Criminal Justice The Perfect Storm Frederick L. Altice, M.D., M.A. Professor of Medicine and Public Health Yale University (USA) University of Malaya (Malaysia)

2 Prisons and Tuberculosis ●Nearly 10 million people imprisoned (4-6X more transition through annually) ●Highly dynamic and unpredictable movement - Police detention - Compulsory drug detention centers - Jails (remand) - Prisons ●TB & HIV significantly concentrated in prisons - Overcrowding & poor nutrition - Increased “selection” of high risk persons entering prisons (PWIDs, homeless, PWLHA)

3 Communities Other Prison Settings Creating the Perfect Storm

4 Tuberculosis in Prisons ●TB outbreaks reported in many prisons, especially MDR-TB in FSU (but also in high income countries with low TB prevalence). ●Prison-related TB transmission is more likely to be drug-resistant or associated with HIV co- infection. ●A higher proportion of TB patients in prisons have MDR-strains than is the case in patients outside prison (incomplete treatment due to release and poor treatment standards). WHO Europe, Prison health – HIV, drugs and tuberculosis, 2009

5 HIV Segregation and TB Outbreaks ●PLWHA are at increased risk for acquisition and progression to active TB ●Entry into a HIV segregation unit by a single active TB case results in a high probability of TB transmission and disease progression ●Crowding and poor ventilation results in increased transmissibility ●Inadequate screening, poor isolation procedures, substandard treatment and default on treatment post-release results in development of drug-resistant strains

6 Prisons, TB and HIV ●50-80% of prison-related mortality related to TB (especially TB/HIV coinfection) ●The War on Drug Users has resulted in incredibly high prevalence of PWIDs / drug dependent persons in prisons (up to 50%) in some settings (Eastern Europe and SE Asia) ●Prisons are “high risk” work environments for staff, especially related to TB (some staff HIV+) ●Nearly all prisoners return to the community and amplify TB risk to family and the general public

7 Case Study: Malaysia ●Middle income country: 102 TB cases/100,000 ●Prisoners: ~38,000 ●Mandatory HIV testing with segregation: 5-6% ●Nearly all HIV+ prisoners meet criteria for opioid dependence (methadone available) ●No systematic TB screening procedures ●See Poster WEPE467 (Al-Darraji et al) - HIGH cross-sectional active TB prevalence using Gene Xpert plus culture for TB case finding - Symptom-based screening fared poorly

8 LTBI and the Prison Risk Environment 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 36.0% 52.1% Healthcare Workers, MY Rafiza, BMC Infect Dis, 2011 Community SE Asia Dye, JAMA, % Open Prison, Kelantan, MY Margolis, IJTBLD, % Closed Prison Selangor, MY Al-Darraji, BMC Pub Health, % Prison Officers Selangor, MY Al-Darraji, Unpub Data, 2013 TST+ independently correlated with previous incarcerations

9 Prevalence of LTBI Among Prisoners in Kelantan, Malaysia * * *p=0.005 Margolis, IJTBLD, In Press

10 Independent Correlates of TST+ and TB Symptoms (N=259) ●TST reactivity - Previously incarcerated4.61 ( ) Margolis, IJTBLD, In Press ●TB symptoms - Age1.07 ( ) - BMI0.82 ( ) - Negative TST (  CD4)3.46 ( ) AOR (95% CI)

11 Deterministic Compartmental TB Model Susceptible S Latent TB (Recent) L1 Latent TB (Remote) L2 Active TB A TB Recovery R Treatment / Self-Cure ReactivationReinfection Immune Stabilization Reinfection Relapse Rapid Progression

12 Key Assumptions ●Passive diagnosis is baseline simulation to compare interventions against ●Systematic reviews used to generate estimates of intervention sensitivity among HIV-negatives and HIV-positives (CD4 stratification) ●All new screening interventions are annual, independent of HIV status ●HIV prevalence in prison ~5-6% (Malaysia) ●Not any significant MDR-TB strains ●Impact of 4 Screening Interventions Basu S et al, In Preparation

13 Reduction in TB Prevalence Using Various Screening Interventions Basu S et al, In Preparation

14 Reduction in TB Incidence Using Various Screening Interventions Basu S et al, In Preparation

15 Reduction in TB Mortality Using Various Screening Interventions Basu S et al, In Preparation

16 Potential Intervention Approaches to Prevent TB Transmission ●Symptom-based screening ●CXR screening ●Sputum AFB screening ●Gene Xpert +/- culture ●Isoniazid Preventive Therapy (HIV+s? TST+s?) ●Routine HIV Testing and Provision of ART ●Increase Ventilation ●UV light ●Specialty TB Prisons ●Stop HIV segregation Improve Screening for TB Methods Decrease Host Susceptibility to TB Infection Alter Prison Environment ●Alternatives to incarceration for PWIDs ●OST for PWIDs Structural Changes

17 Simultaneous Use of Different Classes of TB Control Strategies

18 Isoniazid Preventive Therapy in Correctional Facilities ●18 studies reviewed, including prisons (N=7) and jails (N=11) ●None included low or middle income countries (USA, Spain, Singapore) ●Completion rates markedly lower in jails than in prisons ●Requires ruling out active TB ●Not examined in high prevalence setting of PWIDs where HCV prevalence high (hepatoxicity) Al-Darraji, IJTBLD, 2012

19 Summary ●Good prisoner health IS good public health! ●Approaches to increase detection and treatment of TB in communities should be applied to prisons where the epidemic is concentrated ●Alternatives to reduce incarceration should be considered paramount to optimal TB control ●Will need to examine the impact of combination clinical TB prevention in real-world settings and apply them to High, Middle and Low Income settings

20 Acknowledgements ●University of Malaya - Haider Al-Darraji * - Adeeba Kamarulzaman ●Yale University - Jeffrey Wickersham ●Sanjay Basu – Stanford ●Fabienne Hariga – UNODC ●Malaysia Prisons Department ●Sergey Dvoryak – UIPHP ●Lucas Weissing ●Study participants!